Argus Research analyst John Staszak downgrades Central Garden & Pet (NASDAQ:CENT) from Buy to Hold.
4 Analysts Have This to Say About Forma Therapeutics Hldgs
Within the last quarter, Forma Therapeutics Hldgs (NASDAQ:FMTX) has observed the following analyst ratings: